Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May-Jun;31(3):419-423.
doi: 10.21873/invivo.11076.

Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases

Affiliations

Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases

Toshiaki Yoshimoto et al. In Vivo. 2017 May-Jun.

Abstract

Background: Surgical resection is currently considered the only potentially curative option as a treatment strategy of colorectal liver metastases (CRLM). However, the criteria for selection of resectable CRLM are not clear. The aim of this study was to confirm a new prognostic indicator of CRLM after hepatic resection.

Patients and methods: One hundred thirty nine patients who underwent initial surgical resection from 1994 to 2015 were investigated retrospectively. Prognostic factors of overall survival including the product of maximum diameter and number of metastases (MDN) were analyzed.

Results: Primary tumor differentiation, vessel invasion, lymph node (LN) metastasis, non-optimally resectable metastases, H score, grade of liver metastases, resection with non-curative intent and MDN were found to be prognostic factors of overall survival (OS). In multivariate analyses of clinicopathological features associated with OS, MDN and non-curative intent were independent prognostic factors. Patients with MDN ≥30 had shown significantly poorer prognosis than patients with MDN <30 in OS and relapse-free survival (RFS).

Conclusion: MDN ≥30 is an independent prognostic factor of survival in patients with CRLM and optimal surgical criterion of hepatectomy for CRLM.

Keywords: Colorectal liver metastases; MDN; prognostic factor.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Overall and relapse-free survival curves of 139 patients with colorectal liver metastases who underwent initial surgical resection.
Figure 2
Figure 2. Kaplan–Meier curves for (a) overall survival and (b) relapsefree survival in patients with colorectal liver metastases (CRLM) of MDN ≥30 and <30.

Similar articles

Cited by

References

    1. Gruenberger T, Bridgewater J, Chau I, García Alfonso P, Rivoire M, Mudan S, Lasserre S, Hermann F, Waterkamp D, Adam R. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. Ann Oncol. 2015;26(4):702–708. - PubMed
    1. Lam VW, Pang T, Laurence JM, Johnston E, Hollands MJ, Pleass HC, Richardson AJ. A systematic review of repeat hepatectomy for recurrent colorectal liver metastases. J Gastrointest Surg. 2013;17(7):1312–1321. - PubMed
    1. Lam VW, Laurence JM, Johnston E, Hollands MJ, Pleass HC, Richardson AJ. A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB. 2013;15(7):483–491. - PMC - PubMed
    1. Umehara M, Umehara Y, Takahashi K, Murata A, Nishikawa S, Matsuzaka M, Tanaka R, Morita T. Preoperative Chemotherapy with Bevacizumab Extends Disease-free Survival After Resection of Liver Metastases from Colorectal Cancer. Anticancer research. 2016;36(4):1949–1954. - PubMed
    1. Saied A, Katz SC, Espat NJ. Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases. Hepatobiliary Surg Nutr. 2013;2(2):97–107. - PMC - PubMed

LinkOut - more resources